Europe gives OK to Pfizer-BioNTech vaccine for almost immediate use
The European Medicines Agency is also reviewing the similar Moderna vaccine
21 December 2020 - 17:00
Pfizer and BioNTech’s Covid-19 vaccine has won the backing of the European medicines regulator, clearing the way for inoculations to start before the end of 2020 as the continent struggles with rising death rates and tighter lockdowns.
The endorsement of the vaccine, Comirnaty, was announced in a news briefing by the European Medicines Agency (EMA) on Monday. The final step in approval is a sign-off from the European Commission, expected later in the day...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.